2Torres A, Rello J. Update in community-acquired and nosocomial pneumonia 2009. Am J Respir Crit Care Med, 2010,181:782-787. 被引量：1
3Torres A, Ewig S, Lode H, et al. Hospital-acquired pneumonia in Europe. Eur Respir J, 2009,33 : 951-952. 被引量：1
4Pugin J. Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol, 2002, 68:261-265. 被引量：1
5Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis, 2010, 51 Suppl 1: S131-S135. 被引量：1
6Palazzo SJ, Simpson T, Schnapp L. Biomarkers for ventilator-associated pneumonia: review of the literature. Heart Lung,2011,40:293-298. 被引量：1
7Fica CA, Cifuentes DM, Herve EB. Update of the consensus document on ventilator-associated pneumonia: part I : Diagnostic aspects. Rev Chilena Infectol, 2011,28 : 130-151. 被引量：1
8Luyt CE, Combes A, Reynaud C, et al. Usefulness of proealcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med, 2008,34 : 1434-1440. 被引量：1
9Ramirez P, Garcia MA, Ferret M, et al. Sequential measurements of procalcitonin levels in diagnosing ventilatorassociated pneumonia. Eur Respir J, 2008,31 : 356-362. 被引量：1
10Chen YC. Critical analysis of the factors associated with enteral feeding in preventing VAP: a systematic review. J Chin Med Assoc,2009,72 : 171-178. 被引量：1
